Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Paxene launched in the Czech Republic

Aug. 4, 1999

Kirin Brewery patents quinoline derivatives with broad potential therapeutic application

Aug. 3, 1999

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Aug. 3, 1999

Ontogen completes phase I bioavailability study of MDR-modulating compound

Aug. 3, 1999

Solimastat is a potent MMP inhibitor with significant advantages over related compounds

Aug. 2, 1999

New apoptosis inducers claimed by Takara Shuzo

Aug. 2, 1999

Anti-VEGF enhances efficacy of radiation therapy

Aug. 2, 1999

NuOncology Labs awarded U.S. patent for anticancer compounds

Aug. 2, 1999

Pharmacokinetic and efficacy studies reported for novel prostate cancer drug

Aug. 2, 1999

Bavarian Nordic to begin phase II study of pancreatic cancer therapy

July 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026